More particularly preferred is the use of the inventive active substance combination for the manufacture of a medicament for prophylaxis and/or treatment of obesity, cognitive disorders, memory disorders, or senile dementia processes, such as Alzheimer's, Parkinson's and/or Huntington's Disease.